Chewing Tobacco and Spinal Fusion: Impact and Management
Patients using chewing tobacco (smokeless tobacco) before spinal fusion should be counseled about increased risk of complications and strongly advised to quit, as chewing tobacco significantly increases reoperation rates, pseudarthrosis, and revision surgery risk—though the evidence shows it carries less risk than cigarette smoking.
Risk Profile of Chewing Tobacco vs. Smoking
The evidence demonstrates a clear hierarchy of risk:
Chewing tobacco users face significantly worse outcomes than non-users 1:
- 41% increased risk of pseudarthrosis
- 57% increased risk of revision surgery
- 32% increased risk of any spine-related complication
However, chewing tobacco is less harmful than cigarette smoking 1:
- 16% lower pseudarthrosis risk compared to smokers
- 51% lower infection/incision and drainage risk compared to smokers
- 19% lower overall spine-related complications compared to smokers
For cervical fusion specifically, recent data shows smokeless tobacco users had no increased complications compared to tobacco-naive patients, while cigarette smokers had substantially elevated risks including 2.72 times higher 180-day mortality 2.
Evidence-Based Counseling Approach
What to Tell Patients
All tobacco users (including chewing tobacco) undergoing spinal fusion must be counseled about increased reoperation risk (Grade B recommendation) 3. The Congress of Neurological Surgeons guidelines establish this as standard of care.
Specifically inform patients that:
- Tobacco use of any form increases pseudarthrosis and revision surgery rates
- Chewing tobacco delivers up to 4 times the nicotine dose of smoking 1
- The nicotine itself—not just smoke—impairs bone healing and fusion
Cessation Timing Recommendations
Critical caveat: While guidelines strongly recommend counseling for cessation, there is insufficient evidence that preoperative smoking cessation decreases reoperation risk (Grade Insufficient) 3. However, patients should still be counseled to abstain before and after surgery.
The best available evidence on timing:
Postoperative cessation is more important than preoperative duration 4:
- Patients who quit smoking for >6 months after surgery had nonunion rates of 17.1% (similar to nonsmokers at 14.2%)
- Continued smokers had 26.5% nonunion rates
- Preoperative smoking quantity or duration of preoperative cessation did NOT significantly affect outcomes
- Return-to-work achieved in 75% of post-surgical quitters vs. 53% of continued smokers
For preoperative cessation when possible 5:
- Smoking cessation can increase fusion rates to near those of nonsmokers
- Any cessation attempt is beneficial, though optimal duration remains undefined
Practical Management Algorithm
Preoperative Assessment
- Screen all patients for tobacco use including chewing tobacco, e-cigarettes, and nicotine pouches
- Document nicotine dependence using ICD-10 codes for tracking
- Counsel on specific risks: Use concrete numbers (41% increased pseudarthrosis, 57% increased revision risk for chewing tobacco users)
Cessation Strategy
- Initiate cessation support immediately upon surgical decision, regardless of surgery timing
- Emphasize postoperative abstinence as equally or more important than preoperative cessation
- Provide pharmacotherapy: Consider varenicline or bupropion (both safe and effective) 6
- Arrange follow-up: Minimum 1-month smoking cessation clinic follow-up post-discharge 6
Timing Considerations
- Do not delay necessary surgery for cessation attempts—no evidence supports specific preoperative duration requirements 3
- Intensive interventions 4-8 weeks preoperatively reduce complications when feasible 6
- Cessation at any time does not increase complication risk 6
Important Caveats
Non-tobacco nicotine products (e-cigarettes, pouches) carry similar or worse risks 7, 8, 9:
- E-cigarette users show 37% increased pseudarthrosis at 2 years 7
- Higher rates of pneumonia, renal failure, and sepsis within 90 days 8
- Increased opioid dependence and emergency department utilization 9
The mechanism is nicotine-mediated, not smoke-specific—all nicotine delivery systems impair bone healing and should be addressed equally aggressively.
Patient satisfaction is affected: Smokers are less likely to report they would undergo the same surgery again, even when functional outcomes are similar 5.